Shanghai Pulmonary Hospital, Shanghai, China
Clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, explained in plain language.
-
New combo attack on lung cancer before surgery
Disease control OngoingThis study is testing a new treatment approach for people with operable non-small cell lung cancer. Before surgery, patients receive a drug called toripalimab (an immunotherapy) combined with a precise, high-dose radiation technique called SBRT. The goal is to see if this combina…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Targeted drug tested to shrink tumors before lung cancer surgery
Disease control OngoingThis study is testing whether a targeted drug called sunvozertinib can shrink tumors in people with a specific type of lung cancer before they have surgery. It is for adults with stage II-IIIB non-small cell lung cancer that has a particular genetic change called an EGFR exon 20 …
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC